Home›People›Robert Clayborough
RC

Robert Clayborough

Chief Scientific Officer and director at Rhinal Therapeutics.

ExecutiveDirector
Updated Nov 17, 2026·Latest SEC filing Aug 7, 2025·Suggest an edit

About Robert Clayborough

Robert Clayborough is a chief scientific officer and director at Rhinal Therapeutics.

Experience

This experience comes from SEC filings. The years are when the filings name Robert Clayborough in the role, so the role may have started earlier or lasted longer.

Rhinal Therapeutics Inc.
Chief Scientific Officer and director
2025 · Las Vegas, NV
Develops nasal powder treatments for people with conditions including obesity and diabetes.

Key Colleagues at Startups

The people Robert Clayborough works with at each company, as listed on that company's latest Form D.

Rhinal Therapeutics Inc. · Form D, Aug 7, 2025
LF
Lawrence Fox
Co-Founder and Chief of Operations Officer, director
MG
Mike George
Director
AP
Austin Panhans
Chief Financial Officer
FP
Frank Puglisi
Co-founder, Chief Clinical Officer and director

Sources

  1. SECRhinal Therapeutics Inc. Form D, filed Aug 7, 2025